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Dlk1 and Gtl2 are reciprocally imprinted neighboring genes located within a 1 Mb imprinted domain on murine distal chromosome 12. The
two genes are expressed and developmentally regulated during mammalian embryogenesis. Dlk1/Pref1 encodes a transmembrane protein with
homology to members of the Notch/Delta developmental signaling pathway and Gtl2 generates alternatively spliced poly-adenylated transcripts
lacking a conserved open reading frame. An intergenic differentially methylated region (IG-DMR) located 13 kb upstream of Gtl2 has been shown
to regulate imprinting throughout the domain by an as yet unknown mechanism. In order to gain insights into regulation at this domain and to
compare it with imprinting control at other loci, we compared the expression profile of Dlk1 with Gtl2 during mouse embryogenesis in normal
conceptuses and in those with uniparental disomy for chromosome 12. The expression profile of these genes suggests a causative role for Dlk1
and Gtl2 in the pathologies found in uniparental disomy animals, characterized by defects in skeletal muscle maturation, bone formation, placenta
size and organization and prenatal lethality. Here, we show restricted overlap in cellular expression of these two genes throughout development.
Dlk1 is imprinted and expressed in cell types within the lung, liver and placenta where Gtl2 is not expressed. Gtl2 is highly expressed in the
central nervous system (CNS), whereas Dlk1 is found localized to specific regions such as the hypothalamus. Co-expression is observed in most
of the mesodermal-derived tissues, notably the skeletal muscle where both genes are strongly co-expressed. In this tissue, Dlk1 shows a relaxation
of imprinting with some expression from the maternal allele. These findings indicate that the general mechanism of imprinting at the stages
analyzed is not through the co-ordinate non-coding RNA or insulator mechanisms observed for other imprinted domains, and suggest that the two
genes have independent tissue-specific functions.
© 2007 Elsevier Inc. All rights reserved.Keywords: Dlk1; Gtl2; Imprinting; Non-coding RNA; Insulator; Uniparental disomy; Mouse developmentIntroduction
Genomic imprinting is an epigenetic process described in
mammals and flowering plants by which a gene is differentially
expressed according to the parental origin (Ferguson-Smith and
Surani, 2001; Reik and Walter, 2001). One remarkable feature
of most imprinted genes is their clustering in physically linked
chromosomal positions. Such an organization implies co-
ordinate regulation of the imprinting of multiple genes within
the cluster. The presence of long non-coding RNAs (ncRNAs)⁎ Corresponding author. Fax: +01223 333 786.
E-mail address: afsmith@mole.bio.cam.ac.uk (A.C. Ferguson-Smith).
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doi:10.1016/j.ydbio.2007.02.043is also a recurrent feature of imprinted domains and a role for
repression of transcription of the neighboring genes in cis has
been proposed for some of these non-coding genes (O'Neill,
2005).
Two general models have been advanced to explain
imprinting regulation. The insulator model (proposed for the
Igf2/H19 cluster) and the ncRNA model (proposed for the
Igf2r/Air and the Kncq1/Kcnq1ot1 clusters) (Ferguson-Smith et
al., 2004; Reik and Walter, 2001). The insulator model posits
that imprinting is regulated by an element that confers acces-
sibility to shared enhancers. This is illustrated by the Igf2/H19
cluster, where differential binding of the insulator protein CTCF
to the maternal and paternal chromosomes mediated by dif-
ferences in DNA methylation, regulates which gene promoter
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et al., 2000; Kanduri et al., 2000; Szabo et al., 2000). Consistent
with the use of shared enhancers, these genes show a significant
degree of co-expression. In tissues where their expression is not
co-regulated (the choriod plexus and leptomeninges), they are
not imprinted (Charalambous et al., 2004; Ohlsson et al., 1994).
In the case of the ncRNA model, the expression of the
ncRNA negatively regulates the expression of the imprinted
genes in cis on that chromosome. This regulatory mechanism
has been proposed for the Igf2r/Air and Kcnq1/Kcnq1ot1
clusters of imprinted genes. Truncation of the ncRNAs, Air and
Kcnq1ot1 leads to loss of imprinting in the respective loci
(Mancini-Dinardo et al., 2006; Sleutels et al., 2002), demon-
strating a crucial role for these non-coding transcripts in cis-
acting regional repression. These ncRNAs are very long poly-
adenylated mRNAs that are rarely spliced and are typically
located in the nucleus (Seidl et al., 2006). The precise
mechanism of cis-silencing involving these non-coding tran-
scripts remains unknown. For example, they could act by a Xist-
like mechanism, as happens on the inactive X chromosome,
whereby the ncRNA coats the chromosomal region attracting
repressive epigenetic modifications (Brockdorff, 1998). Alter-
natively, silencing of neighboring genes may be achieved by the
process of transcription of the ncRNA across much of its locus,
perhaps affecting the function of domain regulators (Pauler and
Barlow, 2006). The truncation experiments cannot distinguish
between these two possibilities.
The distal portion of mouse chromosome 12 was originally
shown to contain imprinted genes of developmental importance
from phenotypic studies in both mice containing uniparental
duplications of this region (MatDi(12)—maternal disomy for
chromosome 12 and PatDi(12)—paternal disomy 12) (Geor-
giades et al., 2000; Tevendale et al., 2006), and from
observations in patients harboring uniparental duplications of
the orthologous region on human chromosome 14q—UPD14
(Georgiades et al., 1998; Kagami et al., 2005; Kotzot, 2004).
This distal portion of mouse chromosome 12 contains a 1 Mb
imprinted cluster that contains three protein-coding genes
expressed from the paternally inherited chromosome (Dlk1/
Pref1, Rtl1 and Dio3). Large and small non-coding RNAs are
expressed from the maternally inherited chromosome, including
Gtl2, C/D small nucleolar RNAs (snoRNAs), intergenic
transcripts and several microRNAs (isolated or clustered in
anti-Rtl1 and Mirg transcripts) (Cavaille et al., 2002; Schmidt
et al., 2000; Seitz et al., 2004; Seitz et al., 2003; Takada et al.,
2000; Tierling et al., 2006; Tsai et al., 2002). Dlk1 and Gtl2 lie
at the proximal end of the cluster. Dlk1 encodes a trans-
membrane protein belonging to the Notch/Delta/Serrate family
of signaling molecules (Jensen et al., 1994; Laborda et al.,
1993). As expected for a member of this family, Dlk1 plays
roles in the differentiation of several tissues (Laborda, 2000;
Moon et al., 2002; Smas and Sul, 1993) and is a strong causal
candidate for the muscle, bone and placental defects found in
MatDi(12) and PatDi(12) conceptuses (Georgiades et al.,
2000, 2001; Moon et al., 2002; Tevendale et al., 2006). Gtl2
was initially identified by a random gene trap insertion
upstream of its promoter that was found to affect neonatalembryo size upon paternal transmission (Schuster-Gossler
et al., 1996). Gtl2 is expressed exclusively from the maternally
inherited chromosome and has many splice forms that lack
conserved open reading frames (Schuster-Gossler et al., 1998).
Gtl2 could be part of a large polycistronic transcription unit
that covers additional parts of the imprinted domain, including
themiRNAs and snoRNAs (Lin et al., 2003; Tierling et al., 2006).
The function, if any, of Gtl2 and associated transcripts in
imprinting regulation (in cis or trans) and embryonic develop-
ment is not known. Imprinting across the 1 Mb domain is
regulated by an intergenic germline-derived differentially
methylated region (IG-DMR) located between Dlk1 and Gtl2.
Deletion of the IG-DMR on the maternal chromosome (ΔIG-
DMRMAT) causes an epigenotype switch, i.e., the domain now
exhibits the transcriptional profile of the paternal chromosome
(Lin et al., 2003; Takada et al., 2002). The phenotype of embryos
harboring this deletion is the same as those with PatDi(12)
(Lin et al., 2007).
In order to gain further insight into the mechanism of
imprinting regulation in the Dlk1/Dio3 imprinted cluster, we
undertook a detailed analysis of cell-type-specific expression of
the Dlk1 and Gtl2 genes throughout mouse development to
evaluate the extent of overlapping expression. Results were
compared with those at other imprinted domains. Analysis of
Dlk1 and Gtl2 expression was also assessed in MatDi(12) and
PatDi(12) conceptuses to study the tissue-specific imprinting
status of these genes and to understand the putative role of Dlk1
and Gtl2 in the phenotypic abnormalities of these conceptuses.
These studies provided insights into a functional relationship
between these two genes during development.
Materials and methods
Generation and genotyping of Di(12) conceptuses
MatDi(12) and PatDi(12) animals were generated and genotyped as des-
cribed (Georgiades et al., 2000). Di(12) and normal (C57BL/6 strain) embryos
were harvested at embryonic days 10 (E10), E14, E15, E16, E18 and E19 (day of
vaginal plug being E1).
Histology
The freshly harvested embryos were fixed in 4% paraformaldehyde
overnight at 4 °C, dehydrated and embedded in paraffin wax using standard
protocols. Sections of 7–10 μm were cut and 1 section in 10 was stained with
hematoxylin and eosin (H&E) (Drury and Wallington, 1980).
In situ hybridization protocol
Sense and antisense 35S-labeled riboprobes were generated for both Dlk1
and Gtl2. The Dlk1 riboprobe was synthesized using a full-length Dlk1 cDNA
clone in pBluescript plasmid as a template. The antisense probe was transcribed
from the T7 promoter after linearization of the plasmid with NotI, and the sense
probe was transcribed from the T3 promoter after linearization with BglII.
The Gtl2 riboprobe was synthesized from clones generated after PCR from
genomic DNA using the following primers: Ex3F1 5′-ATTCCGGAACCCAC-
TACCA-3′ and Ex3R 5′-CATCTTGCTGGCAACTCCGT-3′ to generate a 383-
bp product corresponding to exon 3. The reaction mix was as follows: 1× buffer,
1.5 mM MgCl2, 0.25 mM dNTPs, 0.25 μM of each primer, 2.5U Taq DNA
polymerase (Promega) in a total volume of 25 μl. The cycling parameters were
30 cycles of 95 °C 30 s, 55 °C 30 s and 72 °C 1 min. The Gtl2 PCR product was
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protocol) and cloned into pCRII-TOPO vector (Invitrogen) according to
manufacturer's instructions. The Gtl2 antisense riboprobe was transcribed from
the T7 promoter after linearization of the plasmid with HindIII. For the sense
control riboprobe, transcription was achieved from the SP6 promoter after NotI
linearization.
Sense riboprobes were used both as a negative control and to detect any
stable antisense transcripts sometimes associated with imprinted genes. In no
instance did significant signal emerge from the use of sense riboprobes, thus no
stable antisense transcripts were detectable in the region spanning allDlk1 exons
or exon 3 of Gtl2 (Supplementary Figs. 1A–B, D–E, G–H; Figs. 4D, H).
Mid-sagittal sections were treated and hybridized as described previously
(Georgiades and Brickell, 1997; Wilkinson and Nieto, 1993). Sections were
initially exposed on a Phosphoimager overnight to judge the exposure time
necessary. The slides were dipped at 42 °C in Ilford K5 emulsion diluted 3:4
with 2% glycerol in ddH2O. They were air dried overnight, before exposing at
4 °C. Exposure time was 5 days for both Dlk1 and Gtl2. The slides were
developed for 5 min in Kodak D19 developer, rinsed, then fixed in Kodak Unfix
for 5 min before being washed. Slides were counterstained with H&E.
DLK1 immunohistochemistry
The DLK1 antibody (Pref-192) was a kind gift from Prof. C. Carlsson
(Department of Cell Biology, Hagedorn Research Institute, Gentofte, Denmark).
It was raised against both the intracellular (1102–1425 bp) and extracellular
(211–299 bp) domains of the rat DLK1 (PREF-1) protein, which has 96%
homology to the mouse DLK1 protein (Carlsson et al., 1997).
Midsagittal sections were dewaxed in xylene and rehydrated through
decreasing concentrations of ethanol in ddH2O. Antigen retrieval was
achieved by incubating the slides in sodium citrate pH 6.0 (AnalaR) for
5 min in a microwave (power 500 W). After the washes with PBS (2×
5 min), the slides were incubated in 3% H2O2 PBS for 10 min to block any
endogenous peroxidase activity. The slides were then blocked with normal
goat serum (NGS) (Vector Laboratories) overnight at 4 °C. The following
day, DLK1 antibody (PREF-192) was used at a 1:100 dilution in 10% NGS
and the slides were incubated at 4 °C overnight. After a series of washes (3×
1 h) with 0.1% Tween in PBS, the slides were incubated with a 1:500 dilution
of the secondary antibody (biotinylated rabbit anti-goat IgG, Vector
Laboratories) in 10% NGS, at room temperature for 45 min. As a negative
control, slides were hybridized with the secondary antibody in the absence of
the DLK1 antibody. The secondary antibody was visualized using the Elite kit
(Vector Laboratories) following the manufacturer's protocol. The sections
were counterstained with hematoxylin.
RNA extraction and Northern protocol
We isolated total RNA from E19 embryonic tissues from a MatDi(12) and a
normal littermate using the acid guanidium thiocyanate–phenol–chloroform
method (Chomczynski and Sacchi, 1987) as previously described (Paulsen et al.,
2001). mRNAwas isolated from total RNA using Dynalbeads Oligo (dT)25 kit
(Dynal), following the supplied protocol. We carried out Northern blot
hybridization and used Dlk1 and Gapdh probes as described previously (Takada
et al., 2000). Expression was quantified using a Storm 860 Phosphorimager
(Amersham) and associated ImageQuant software according to manufacturer's
instructions. For RT-PCR analysis, RNA was isolated from tissues dissected
from E16 embryos derived from reciprocal crosses between DBA/2 and
C57BL6. cDNA was synthesized and RT-PCR was conducted as described
previously (Lin et al., 2003).
Results
Dlk1 and Gtl2 expression profile
Less discriminating methods have previously suggested co-
expression of Dlk1 and Gtl2. As shown previously using RT-
PCR and Northern Blot analysis (Schmidt et al., 2000; Takadaet al., 2000), both Dlk1 and Gtl2 are widely though not
ubiquitously expressed throughout embryogenesis and appear
to be expressed in the same tissues. Downregulation of their
expression occurs tissue-specifically, pre- and post-partum.
They are both expressed in trophoblast and inner cell mass
derivatives and in lineages derived from the three primary germ
layers: endoderm, mesoderm and ectoderm (Fig. 1). Here, in
situ hybridization and immunostaining of normal embryo and
placenta sections from stages E10, E14, E15, E16 to E19,
combined with Gtl2 data previously published by Schuster-
Gossler et al. (1998) and Yevtodiyenko and Schmidt (2006),
indicate that Dlk1 and Gtl2 are restricted in their cell-specific
co-expression, with some exceptions.
Ectodermally derived tissues
Gtl2 is expressed strongly in the central nervous system
(CNS) where it is first detected at E10 in the diencephalon
overlying Rathke's pouch and in the pouch proper (Schuster-
Gossler et al., 1998). At E15, Gtl2 is expressed highly in the
diencephalon (both thalamus and hypothalamus) and medulla
oblongata (Fig. 1A). Besides, the brain, Gtl2 is highly
expressed in the spinal ganglia and spinal cord (Fig. 1D and
2J). In the CNS, Gtl2 is mainly found in the nucleus of the cells
(Table 1 and Schuster-Gossler et al., 1998). Dlk1 expression in
the brain based on mid-sagittal sections is low and confined to
the membrane of few cells of the diencephalon both in the
thalamus and more strongly in the hypothalamus and the optic
recess (Figs. 1B–C). These cell types also express Gtl2 (Fig.
1A, Table 1). Expression of Dlk1 in the developing brain might
not be confined to these regions but also to other regions as
suggested by studies in rats and humans such as neurons of the
Edinger–Westphal's nucleus, substantia nigra, ventral tegmen-
tal area, locus coeruleus and certain parts of the raphe nuclei
(Jensen et al., 2001). Dlk1 is not expressed in the spinal ganglia
and spinal cord (Figs. 1 and 2K–L).
In situ hybridization data for both genes in the adult brain are
available from the recently published Allen brain atlas project
(www.brain-map.org) (Lein et al., 2007). Consistent with the
embryonic expression, Gtl2 exhibits widespread expression
throughout the brain. In contrast, Dlk1 expression is highly
localized to a few regions, including the nucleus accumbens and
several areas within the hypothalamus, such as the suprachias-
matic nucleus, the arcuate nucleus, the supraoptic nucleus and
the paraventricular hypothalamic nucleus. Thus, Dlk1 and Gtl2
transcript distribution in adult brain is suggestive of indepen-
dent functions of the two genes.
One of the most prominent sites of Dlk1 and Gtl2 expression
in the brain is the developing pituitary gland. The pituitary gland
is developed from two tissues of distinct origins: the anterior
lobe (including the pars intermedia and pars distalis) arises from
a diverticulum of the oral ectoderm termed Rathke's pouch; the
posterior lobe (pars neuralis) results from a downgrowth from
the floor of the diencephalic portion of the primitive forebrain,
the infundibulum. From E10 to E13, both Dlk1 and Gtl2 are co-
expressed in the Rathke's pouch and in the infundibulum that
precede the formation of a morphologically normal pituitary
Fig. 1. Gtl2 and Dlk1 expression in the mid-gestation embryo and placenta at E15–E16 of gestation. Mid-sagittal sections of the head (A–C: light field), thorax (D–F:
light field) and placenta (G–H: dark field; I: light field) hybridizedwithGtl2 (A, D andG) andDlk1 (B, E and H) antisense riboprobes and immunostained withα-DLK1
antibody Pref-192 (C, F and I). The genes are co-expressed in some tissues such as the pituitary, skeletal muscle, placenta, but onlyGtl2 expression is observed inmost of
the CNS and Dlk1 but not Gtl2 is expressed in the lungs. Panel D inset—Gtl2 nuclear staining of developing skeletal muscle. Scale bar: 50 μm. Abbreviations: Ch—
choroid plexus; CP—chorionic plate; D—decidua basalis; Di—diaphragm; F—forebrain; He—heart; Hy—hypothalamus; IM—intercostal muscle; Jz—junctional
zone; Li—liver; Lu—lung; Lz—labyrinthine zone; Mid—midbrain; OR—optic recess of diencephalon; Pit—pituitary; SpC—spinal cord; T—thalamus; To—tongue.
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Yevtodiyenko and Schmidt, 2006). Interestingly, at E15, when a
morphologically mature pituitary gland is formed, Dlk1 is
strongly expressed in the posterior pituitary (in the membrane
and granular staining in the cytoplasm) and weakly expressed in
the anterior pituitary, while Gtl2 expression remains strong in
the two lobes (Figs. 2A–C).Gtl2 transcripts are not concentrated
in the nuclei in contrast to the majority of the other expressing
tissues (Figs. 2A, Table 1). Dlk1 expression remains to
adulthood in the somatotrophic cells of the adenohypophysis
(Larsen et al., 1996) andGtl2 to the neurohypophysis, notably in
gonadotrophic cells (Zhang et al., 2003).
Mesodermally derived tissues
In the embryonic mesoderm, Gtl2 commences expression in
presomitic mesoderm and with ensuing development becomes
restricted to the myotome and its derivatives (Schuster-Gossler
et al., 1998). It is detected at high levels in the tongue,
intercostal muscle and the diaphragm until late in gestation (Fig.
1D and data not shown). Gtl2 transcripts are mainly located in
the nuclei (Fig. 1D inset, Table 1 and Schuster-Gossler et al.,
1998). In contrast, Dlk1 is more extensively expressed in
mesoderm, in the dermomyotome, myotome and sclerotome of
the somites at E10, after which it is expressed in the skeletal
muscle and cartilage until term (Figs. 1E–F and 6).Skeletal muscle is the tissue where Dlk1 and Gtl2 are most
strongly expressed (also noted by Schuster-Gossler et al., 1998
and Yevtodiyenko and Schmidt, 2006). In contrast, neither of
the genes are expressed in cardiac muscle (Figs. 1D–F). Dlk1
and Gtl2 are both expressed in the primordial cartilage of
different types of bones (Figs. 1D–F). Co-expression of the two
genes is observed in this tissue, although levels of Gtl2 varied
considerably between independent experiments (also noted in
Schuster-Gossler et al., 1998).
No expression was observed in the kidney for Dlk1 or for
Gtl2. Dlk1 is also strongly expressed in the cortex of the adrenal
gland, where Gtl2 is weakly expressed (Fig. 4J and data not
shown). Expression in the adult adrenals is maintained for both
genes (Schmidt et al., 2000).
Endodermally derived tissues
In the liver, Glt2 and Dlk1 are expressed in some fetal
hepatic cells, shown for Dlk1 to be hepatoblasts and immature
hepatocytes (Tanimizu et al., 2003). Dlk1 is widely expressed in
the cytoplasm of the majority of hepatic cells (Figs. 2H–I)
whereas Gtl2 is confined to the nucleus of fewer individual cells
(Fig. 2G). Dlk1 and Gtl2 transcripts were never observed in the
mesodermally derived hematopoietic cells (Figs. 2G–I).
In the pancreas, Dlk1 and Gtl2 are present in both the acini
and in the stroma (Figs. 2D–F). Dlk1 mRNA expression is
Fig. 2. Comparative expression profile of Gtl2 and Dlk1 in different tissues at E15–16 of gestation. Gtl2 (A, D, G, J and M) and Dlk1 mRNA (B, E, H, K and N)
expression and DLK1 protein (C, F, I, L and O). (A–C) Pituitary, (D–F) pancreas; (G–I) liver, (J–L) spinal ganglia and spinal cord. (M–O) Lung. Abbreviations: Ac—
aceni; Br—bronchioles; C—cartilage primordia; H—hematopoietic cells; Hep—hepatic cells; Hy—hypothalamus; Pi—pars intermedia; Pd—pars distalis; Pn—pars
neutralis; SpC—spinal cord; SpG—spinal ganglia; Str—stroma.
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Table 1
Comparison of Dlk1 and Gtl2 expression in tissues and organs of the midgestation embryo
Tissue/Organ Gtl2 (subcellular localization) Dlk1 (subcellular localization) Dlk1/Gtl2 colocalization
Somites Dermomyotome; myotome Dermomyotome (c), myotome (c),
sclerotome (c)
Yes: dermomyotome, myotome
No: sclerotome
Brain Diencephalon—thalamus and
hypothalamus (n)
medulla oblongata (n)
Diencephalon—hypothalamus and
optic recess (m)
No
Pituitary Anterior and posterior lobe (non-n) Anterior and posterior lobe (g and m) Yes: both lobes only at early stages; then,
Gtl2:posterior lobe Dlk1: anterior lobe
Spinal ganglia and spinal
cord
Strong expression (n) No expression No
Endochondral cartilage Weak expression (n and c) Resting and proliferative chondrocytes
(c and g)
Yes
Skeletal muscle: tongue/
diaphragm/intercostal
Myofibers throughout gestation (n) Myofibers throughout gestation
(early stages: g—later: c)
Yes
Cardiac muscle No expression No expression –
Lung No expression Endothelial cells of bronchioles
(mainly m)
No
Liver Individual cells (n) Hepatoblasts (g and c) No (for the majority; few cells
express both Gtl2 and Dlk1)
Pancreas Acini (c), stroma (n) Acini (g and m), stroma (m) Yes
Kidney No expression a No expression –
Intestine Outer epithelium (n)
Gut mesenchyme (c)
Outer epithelium (mainly m) Yes: in the outer epithelium
Placenta
Labyrinth Endothelial cells (n)
Syncytiotrophoblasts cells (n)
Endothelial cells (m) No (Yes in a subset of endothelial cell)
Junctional zone Giant trophoblast cells (n) Glycogen cells (m) No
Decidua basalis Glycogen cells (m) No
Abbreviations for subcellular staining: c—cytoplasmic staining; g—granular staining in cytoplasm; m—membrane; n—nuclear.
a Gtl2 was shown to be expressed in the kidney tubules by Schuster-Gossler et al. (1998), but we did not detect in any stage studied.
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although protein expression is equally observed in both stroma
and acini at E16 (Fig. 2F). During gestation expression of Dlk1
is downregulated first in the acini and later in the stroma, being
absent at late gestation (data not shown). It is restricted to β-
cells where it persists postnatally (Tornehave et al., 1996).
Expression of Gtl2 is also downregulated during gestation, first
in the stroma and later in the acini (data not shown).
Gtl2 is not expressed in the lung, in contrast to Dlk1 that is
expressed strongly in segmental bronchi of the lungs (Figs.
2M–O), where it might have a role in the process of branching
morphogenesis of the lungs (Yevtodiyenko and Schmidt, 2006).
Both Dlk1 and Gtl2 are expressed in the ducts of the salivary
glands (Table 1).
Extraembryonic tissues
In the extraembryonic derivatives, Dlk1 and Gtl2 are
expressed in the yolk sac, chorionic plate and placenta (Fig. 1
and Fig. 3; Supplementary Fig. 3).
In the placenta, Gtl2 mRNA is observed in the labyrinthine
zone (Fig. 3A), with expression restricted to the nucleus of a
subpopulation of fetal endothelial cells and of labyrinthine
trophoblast cells (Fig. 3A). Gtl2 is also expressed in the
nucleus of some trophoblast giant cells in the junctional zone
(Figs. 3D and G).
In contrast, Dlk1 is expressed in all the three layers of the
placenta (labyrinthine zone, junctional zone and deciduabasalis), chorionic plate and yolk sac (Fig. 3 and data not
shown). In the labyrinthine zone it is expressed only on the
membrane of the fetal capillary endothelium (the expression
declines at later stages) (Figs. 3B–C and data not shown) and in
the junctional zone it is found on the membrane of some
glycogen cells and that expression is maintained as these cells
migrate into the decidua basalis (Figs. 3F and I). Curiously,
expression of Dlk1 in the glycogen cells was observed by α-
DLK1 immunostaining but not by in situ hybridization (Figs.
3E–F and H–I). Dlk1 is expressed on the membrane of the
epithelium of the chorionic plate and increases throughout
gestation becoming clearly polarized to the placental side of the
epithelial membrane (data not shown). Expression of Dlk1 in
the yolk sac is seen in the inner mesodermal layer, but never
observed in the outer endodermal component of the yolk sac
(data not shown).
These observations, summarized in the Table 1, clearly
suggest a restricted co-expression of these two reciprocally
imprinted genes. With a few notable exceptions, co-expression
of Dlk1 and Gtl2 is rarely observed in the same cell types even
though the two genes are often expressed in the same tissues.
Expression of Dlk1 and Gtl2 in MatDi(12) and PatDi(12)
In situ analysis and immunohistochemistry were performed
on MatDi(12) and PatDi(12) embryos and placentas to further
investigate the tissue-specific imprinting status of Dlk1 and
Gtl2. Expression of Gtl2 was never found in PatDi(12)
Fig. 3. Comparative expression profile of Gtl2 and Dlk1 in the E14 placenta. Gtl2 (A, D and G) and Dlk1 mRNA (B, E and H) and DLK1 protein (C, F and I). (A–C)
In the labyrinthine zone. (D–I) The junctional zone. Abbreviations: FE—fetal endothelial cells; Syt—syncytiotrophoblast cells; Cyt—cytotrophoblast cells; FC—fetal
capillary; MBS—maternal blood space; TGC—trophoblast giant cell; Spt—spongiotrophoblast cells; GC—glycogen cells; D—decidua basalis.
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ing of this gene. As expected, in MatDi(12) conceptuses, Gtl2
shows increased expression when compared to normal
littermates (Figs. 4A–D and Supplementary Fig. 3) reflecting
the double dose expressed from both maternally inherited
chromosomes. No Gtl2 ectopic expression was observed in the
MatDi(12) conceptuses (Fig. 4A).
Elevated levels of the paternally expressed imprinted Dlk1
were observed in PatDi(12) embryonic and extraembryonic
tissues, and no ectopic expression was observed (Fig. 4G and
Supplementary Fig. 3). Surprisingly, MatDi(12) embryos
exhibit expression of Dlk1 mRNA and protein in skeletal
muscle and to a lesser extent, in the liver (Figs. 4E and J). These
results were confirmed and quantified using Northern blot
analysis on tissues dissected from a E19 MatDi(12) conceptusdemonstrating that Dlk1 expression in MatDi(12) muscle is
approximately 17% compared to normal littermates (Fig. 5). No
expression of Dlk1 in the liver was evident in Northern blot
analysis which may be due to downregulation of Dlk1 in this
tissue by E19.
Expression of Dlk1 in MatDi(12) skeletal muscle suggests
some relaxation of imprinting of Dlk1 in this tissue, i.e., the
pool of Dlk1 transcripts is not only derived from the paternal
allele. Another interpretation is that the maternal Dlk1 allele
becomes activated particularly during MatDi(12) development.
This Dlk1 expression in MatDi(12) skeletal muscle may occur
as a ‘stress’ response within a compromise embryo trying to
thrive, i.e., as a secondary effect. Alternatively, this relaxation of
imprinting might reflect genetic background-specific effects—
the two maternal chromosomes in these fetuses are from Balb/c.
Fig. 4. Gtl2 and Dlk1 expression in MatDi(12) and PatDi(12) at E15–16. Mid-sagittal embryonic sections of MatDi(12) (A, D, E, I), normal (B, F, J, L) and PatDi(12)
(C, G, H, K) embryos hybridized with Gtl2 antisense (A–C) and sense (D) probes, Dlk1 antisense (E–G) and sense (H) probe and α-DLK1 antibody (I–K) and
negative control (L). Gtl2 is appropriately overexpressed in MatDi(12) and absent in the PatDi(12). In contrast, Dlk1 is overexpressed in PatDi(12), while some
mRNA and protein are detected in skeletal muscle and liver of MatDi(12) conceptuses.
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reciprocal hybrid crosses between C57BL/6 and DBA/2 mice
to monitor tissue-specific expression of Dlk1 in normal hybrid
E16 tissues. A G→A single nucleotide polymorphism in the 3′
UTR region of Dlk1 in DBA/2 distinguishes it from the
C57BL/6 allele allowing determination of the parental origin of
the Dlk1 allele (Lin et al., 2003). Sequencing of RT-PCR
products from different tissues from hybrid fetuses shows very
weak expression of the maternal allele in the skeletal muscle
and liver in both reciprocal crosses. In contrast, no expression of
the maternal Dlk1 allele was detected in the brain or lung
(Supplementary Fig. 2). The nature of this albeit limited
analysis is qualitative and not quantitative, therefore, levels ofexpression of the maternal allele cannot be compared between
MatDi(12) and hybrid fetuses.
Our results show that Gtl2 is maternally expressed in
embryonic and extraembryonic tissues, whereas Dlk1 shows
some relaxation of its imprinting in skeletal muscle and liver in
both normal and compromised fetuses on a range of genetic
backgrounds.
Expression profile of Dlk1 in embryonic tissues affected in the
MatDi(12) and PatDi(12) conceptuses
The expression profile of Dlk1 mRNA during development
has been documented both in the mouse and human for a number
Fig. 5. Quantitative expression of Dlk1 in MatDi(12) tissues. (A) Northern blot
for embryonic tissues from MatDi(12) and normal E19 conceptuses. Tissues:
1—placenta; 2—brain; 3—liver; 4—lung; 5—gut; 6—heart; 7—skeletal
muscle; 8—kidney; 9—adrenal; 10—spleen; 11—tongue. (B) Graphic
representation of the relative expression of Dlk1 in E19 tissues of MatDi(12)
and normal conceptuses.
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Schmidt, 2006). As Dlk1 is highly expressed in bone precursors
and skeletal muscle and is a candidate for the skeletal andmuscleFig. 6. DLK1 protein in somite derivatives. (A) DLK1 is expressed in all component
staining of Dlk1 in the skeletal muscle of the tongue (E14). (C) Cytoplasmic staining
proliferating chondrocytes of the cartilage primordia of the turbinate bones. (E) Pro
showing high expression in proliferating chondrocytes, low expression in mature chon
in the proliferating chondrocytes of the turbinate bones. Abbreviations: Am—amnion
Nc—nasal cavity.defects in uniparental disomic conceptuses for chromosome 12,
we considered DLK1 protein expression during myogenesis and
skeletogenesis in more detail.
Dlk1 is expressed in the dermomyotome, myotome and
sclerotome of the somites at E10, after which it is expressed in
skeletal muscle and cartilage until term (Figs. 1E–F and 6A).
From E13 to E15, in the developing muscle, DLK1 is patchy
in the cytoplasm (Fig. 6B), but around E16 (peak of
expression), it appears strongly and more uniform throughout
the cytoplasm of the myofibers. This qualitative staining
persists throughout the rest of gestation as evident from the
staining at E19 (Fig. 6C).
DLK1 protein is found in the sclerotome of somites at E10
and in proliferating chondrocytes from E13, with the peak of
expression at E14 to E16, preceding the period of greatest
ossification (Figs. 6A, D and data not shown). Expression is
also seen in immature resting chondrocytes but not observed in
the perichondrium and later periosteum (data not shown). As the
chondrocytes mature and hypertrophy, they cease to express
Dlk1 (Fig. 6E). The subcellular localization of DLK1 in
chondrocytes always appears to be in cytoplasmic granules
surrounding the nucleus (Fig. 6F).
Discussion
The present study shows that with a few notable exceptions,
Dlk1 and Gtl2 are not co-expressed in a number of cell types
and tissues in which they are both imprinted (Table 1). While
Gtl2 was found to be exclusively expressed from the maternal
chromosome, Dlk1 was shown to be predominantly expressed
from the paternal allele with a slight relaxation of imprinting in
a minority of tissues. These genes are expressed in all the tissues
with reported abnormal phenotypes in MatDi(12) and PatDi(12)
conceptuses.s of the somites (dermatome, myotome and sclerotome). (B) Patchy cytoplasmic
of Dlk1 in the skeletal muscle of the tongue (E19). (D) Dlk1 is expressed in the
gression of Dlk1 expression in the ossification center of the body of a vertebra,
drocytes and no expression in hypertrophic chondrocytes. (F) Staining of DLK1
; PC—proliferating chondrocytes; Ch—hypertrophic chondrocytes; S—somite;
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interactions
The analysis of co-localization of a ncRNA gene and reci-
procally imprinted protein coding genes during embryonic
development is a useful approach for understanding the mecha-
nism of imprinting in the different imprinted clusters. With
exception of the Igf2/H19 cluster (Ohlsson et al., 1994), the
Nesp and its antisense Nespas in the Gnas locus (Ball et al.,
2001), few in situ co-expression studies have been carried out.
In this report, such an analysis was done for the pair of im-
printed genes Dlk1 and Gtl2 on mouse distal chromosome 12.
As summarized in Table 1, co-expression analysis revealed a
restricted pattern of overlapping expression between Dlk1 and
Gtl2. We identified tissues and cell types where Gtl2 is
expressed and Dlk1 is not, such as most of the CNS, part of the
pituitary, syncytiotrophoblasts within the labyrinthine zone and
giant trophoblasts cells in the junctional zone of the placenta.
Similarly, Dlk1, but not Gtl2, is expressed in the bronchioles of
the lungs, the majority of hepatoblasts in the liver and fetal
endothelial cells in the labyrinthine zone of the placenta.
Overlapping expression of Dlk1 and Gtl2 is restricted to
tissues such as the skeletal muscle and cartilage, the stroma of
the pancreas and adrenals, a subset of fetal endothelial cells in
the placenta, in a few cells of the hypothalamus and a small
number of hepatic cells. Neither Dlk1 nor Gtl2 was expressed in
either the heart or the kidney.
These results have implications for understanding imprinting
regulation at this imprinted cluster: first, imprinting of Dlk1
does not appear to depend on Gtl2 expression at least at the
stages analyzed. A role for Gtl2 (and putative maternally
expressed associated transcripts) in cis-acting repression of
neighboring genes had been suggested by the reciprocal
changes in expression levels between maternally and paternally
expressed imprinted genes of the domain in different mouse
models. For example, in the ΔIG-DMRMAT conceptuses,
repression of the non-coding RNAs is correlated with biallelic
expression of paternally expressed genes (Lin et al., 2003). In
another mouse model containing a LacZ transgene inserted
2.3 kb upstream of the Gtl2 gene (Schuster-Gossler et al.,
1996), a slight activation of the normally silent paternally
inherited Gtl2 allele (and associated maternally expressed
transcripts) upon paternal transmission of the transgene is
correlated with a 50% reduction of expression of the paternally
expressed imprinted genes (Sekita et al., 2006; Steshina et al.,
2006). Upon maternal transmission of the LacZ insertion,
reduction of expression of the Gtl2 maternal allele correlates
with activation of the normally repressed Dlk1 maternal allele
(Steshina et al., 2006). One mechanism to explain the reciprocal
changes in the levels of expression in these mouse models is to
attribute variation of expression of the paternally expressed
genes to the changes in levels of the maternally expressed
ncRNA transcripts on the same chromosome. If this were the
case, detection of Gtl2 expression would be where Dlk1
imprinted expression occurs.
Imprinted expression of Dlk1 is observed in tissues that do
not exhibit expression of Gtl2 non-coding RNA. Therefore, atleast in these tissues (such as the lung and a subset of
hepatoblasts and fetal endothelial cells of the placenta),
imprinting of Dlk1 is not explained by cis-acting repression
by Gtl2. This argues against a non-coding RNA model to
explain imprinting regulation at this locus, and therefore Gtl2
might not act like Air or Kcnq1ot1/Lit1 in regional transcrip-
tional repression of reciprocally imprinted genes. We cannot
rule out the possibility that Gtl2 might be co-expressed in the
same tissues as Dlk1 but that its turn-over is so rapid that
transcripts fail to be detected by the methods used here.
Alternatively, more extensive co-expression of these genes at
earlier stages than those assessed in this study (before E10)
might allow Gtl2 to play a role in the establishment of Dlk1
imprinting, but not be required for imprinting maintenance later
in development.
Second, imprinting of Dlk1 and Gtl2 is not associated with a
competition for shared enhancers mediated by a methylation-
sensitive insulator element as described for the Igf2-H19 locus;
Igf2 and H19 show a significant degree of co-expression and
this has been demonstrated to result from the use of shared
enhancer elements located downstream of H19 (Leighton et al.,
1995). In tissues where their expression is not co-regulated (the
epithelium of the choriod plexus and leptomeninges), enhancers
are specific to Igf2 and imprinting is also not evident (Ohlsson
et al., 1994; Charalambous et al., 2004). The lack of an Igf2-
H19 type insulator mechanism at Dlk1-Dio3 is consistent with
the absence of binding sites for the insulator CTCF in the
vicinity of the Dlk1-Gtl2 IG-DMR and substantiated in recent
work showing absence of CTCF binding to this imprinting
control region in vivo (Paulsen et al., 2001; Carr et al., 2007).
The paucity of co-expression and restricted overlapping
pattern of expression suggests that these genes make use of
distinct enhancers. In accordance with this, a 178 kb BAC
transgene starting 3.5 kb upstream of Dlk1 and finishing 69 kb
downstream of Gtl2 transcriptional start site is able to cause
imprinted expression of Gtl2 but not Dlk1 in the brain
(Yevtodiyenko et al., 2004). Another BAC transgene spanning
a region from 50 kb upstream ofDlk1 gene to 19 kb downstream
of Dlk1 transcriptional start site shows strong Dlk1 expression
in the brain (ST da Rocha and AC Ferguson-Smith, unpub-
lished). This locates brain-specific enhancers for these two
genes to distinct genomic locations consistent with their non-
overlapping expression in neural tissues.
Imprinted expression of Gtl2 is confirmed by the absence of
Gtl2 expression in all the PatDi(12) tissues. Curiously, Dlk1
expression is observed in the tongue, intercostal and neck
skeletal muscles, and liver of the MatDi(12) embryos, showing
thatDlk1 can be expressed from the maternal allele at low levels
in skeletal muscle and liver, even though this accounts for a
small proportion of Dlk1 expressed in these tissues (Figs. 4 and
5). These data were confirmed in normal conceptuses
(Supplementary Fig. 2). This tissue-specific relaxed imprinting
may reflect the fact that the two genes are co-expressed in
muscle hence the maternal chromosome, active for Gtl2, may
also be accessible to the Dlk1 muscle-specific regulators albeit
less effectively. While co-expression of the two genes in these
tissues could reflect an active role in imprinting, the finding of
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same chromosome, suggests otherwise.
A role for Gtl2?
Our results suggest that if Gtl2 plays a role in imprinting
control at the locus, it exerts its effect at an earlier time. After
E10, the expression pattern of Gtl2 during embryonic
development compared to Dlk1 indicates that this gene is not
involved in cis-acting regional repression, as imprinting of
Dlk1 is usually independent of Gtl2 expression. Furthermore,
Gtl2 is highly expressed in, for example, the CNS where
Dlk1 is not expressed. We cannot exclude that expression of
Gtl2 in the CNS is regulating imprinting of other maternally
repressed imprinted genes in the clusters (for example Rtl1,
whose transcripts are found in the CNS) (Brandt et al., 2005),
however, the potential exists for Gtl2 and associated transcripts
to have other developmental functions at the stages analyzed
here.
Gtl2 expression is associated with transcriptional activity
along much of the maternal chromosome, hence might at least
in part contribute to a large polycistronic transcription unit
including the miRNAs and snoRNAs located further 3′ (Tierling
et al., 2006). All these transcripts are synthesized in the same
orientation and expressed in the same tissues. Promoter and
regulatory sequences other than the Gtl2 promoter have not yet
been defined (Cavaille et al., 2002; Seitz et al., 2004; Tierling et
al., 2006; Steshina et al., 2006). Thus, Gtl2 might function to
host multiple smaller functional RNAs that regulate genes and/
or their products in trans. Indeed, trans-interactions have been
reported between the miRNAs derived from the maternally
expressed anti-Rtl1 non-coding transcript and the Rtl1 mRNA
expressed on the paternally inherited chromosome. These
miRNAs can cleave the Rtl1 transcript via an RNAi-mediated
mechanism hence modulating Rtl1 transcript levels (Davis et
al., 2005). In addition, miRNAs located at this domain have
been associated with the translational interference of targets
located elsewhere in the genome (Saito et al., 2006; Schratt et
al., 2006). Therefore, if indeed these transcripts belong to the
same long transcriptional unit driven by the same promoter
sequences, the Gtl2 expression profile documented here maps
tissues where such trans-repression might happen during
mouse development. The subcellular location of Gtl2, usually
nuclear, may be functionally relevant (Table 1).
Dlk1 and Gtl2 expression relative to phenotypic abnormalities
in MatDi(12) and PatDi(12) conceptuses
Dlk1 and Gtl2 are co-expressed in skeletal muscle and
cartilaginous precursors of bone and organ systems where
mutant phenotypes have been described in conceptuses with
uniparental disomy of chromosome 12.
Dlk1 is a member of the Notch/Delta/Serrate family of
signaling molecules, known to act in lineage decisions, in
lateral inhibition and boundary formation via cell–cell
communication involving a ligand, Delta or Serrate (Jagged
in vertebrates) and the Notch receptor on an adjacent cell(Bray, 2006). Recent data suggest that the presence of several
splice variants allows Dlk1 to act as a ligand and/or a receptor
in different tissues (Baladron et al., 2001; Li et al., 2005; Mei
et al., 2002) and the absence of a DSL domain, normally
present in the Notch ligands, suggests an inhibitory role in
Notch signaling (Baladron et al., 2005).
Gtl2 is also expressed in tissues where a phenotype was
described in the uniparental disomic conceptuses, however, to
date, no specific function has been attributed to Gtl2. Some
studies suggest that Gtl2 can act as a tumor suppressor gene in
neuroblastomas, phaeochromacytomas and non-functioning
pituitary tumors due to hypermethylation of its promoter
(Astuti et al., 2005; Zhang et al., 2003; Zhao et al., 2005) and
causes inhibition of the growth of several human cancer cell
lines (Zhang et al., 2003) suggesting a potential function for this
non-coding gene in development and disease.
During myogenesis, Dlk1 levels increase dramatically from
E13 to E16. This change in the pattern of expression could
contribute to the muscle maturation defects in the disomic mice
as these commence around E15 (Georgiades et al., 2000). This
window of time is when a second wave of myogenesis occurs, a
process vital for muscle maturation in rodents (Wigmore and
Dunglison, 1998) which is perturbed in uniparental disomic
conceptuses. IfDlk1 is responsible for the muscle phenotypes in
these conceptuses, it is likely to be a negative regulator of
maturation/differentiation, as is also suggested for Delta-1 in
chicken (Hirsinger et al., 2001). Consistent with this, over-
expression of a membrane bound form of Dlk1 (derived from a
sheep cDNA) driven by murine myosin light chain 3F promoter
and 2E enhancer causes muscle hypertrophy and immaturity in
adult mouse (Davis et al., 2004).
Strong arguments could also be raised against a role of Dlk1
in skeletal muscle maturation. First, no defects in muscle
maturation were reported in Dlk1-deficient mice (Moon et al.,
2002). Second, Dlk1 is not fully repressed in MatDi(12)
abnormal skeletal muscle and protein product is detected. Third,
constitutive expression of Dlk1 in c2c12 myoblasts that lack
endogenous Dlk1 expression has no effect on the conversion of
these cells to myotubes (Smas and Sul, 1993). Fourth, we
cannot rule out that another candidate gene such as Rtl1 that is
also expressed at high levels in muscle, could be responsible for
these phenotypes (Brandt et al., 2005). Finally, in vivo
overexpression of Dlk1 driven by its own regulatory elements
does not cause muscle hypertrophy and immaturity in the
embryo (ST da Rocha and AC Ferguson-Smith, unpublished).
In developing bones, the ossification centers themselves are
not targets for gene action and most skeletal defects are due to
conditions affecting the cartilaginous precursors. Skeletal
defects are one of the major features of the uniparental disomic
phenotypes. PatDi(12) embryos show delayed ossification,
cartilage hyperplasia and skeletal overgrowth (Georgiades et al.,
2000). MatDi(12) has no ossification of two of the middle ear
ossicles (malleus and incus) with no delay in ossification in the
rest of the skeleton (Georgiades et al., 2000). Skeletal
abnormalities were seen in Dlk1-deficient mice, including rib
fusions and asymmetrical rib attachment to the sternum (Moon
et al., 2002). In PatDi(12), Dlk1 is overexpressed and in MatDi
821S.T. da Rocha et al. / Developmental Biology 306 (2007) 810–823(12) is repressed. Thus, overexpression of Dlk1 might be
associated with impaired ossification. Interestingly, Dlk1 is
expressed in immature resting chondrocytes and in proliferative
chondrocytes, and downregulated in mature and hypertrophic
chondrocytes. A role as a negative regulator of maturation/
differentiation was postulated for adipose tissue (Smas and Sul,
1993) and the same could occur in bone development as
suggested by in vitro studies (Abdallah et al., 2004). Major
skeletal defects that resemble PatDi(12) abnormalities are
present when Dlk1 is overexpressed in vivo (ST da Rocha and
AC Ferguson-Smith, unpublished).
Further experiments are needed to understand imprinting
regulation at this locus however limited cellular co-expression
of Dlk1 and Gtl2 during fetal development, suggests that the
ncRNA does not regulate the imprinted expression of Dlk1 at
these stages. Targeted mutagenesis of the Gtl2 transcript
should shed light on its function. The presence of small RNAs,
such as snoRNAs and miRNAs is also a remarkable feature of
this cluster. Assessment of their relationship to Gtl2 and their
importance for regulation at this locus and elsewhere, will shed
light on the developmental consequences of the altered dosage
of genes and the evolution of imprinting at this locus.
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